Skip to main content

Artificial Intelligence

By HIMSS TV | 09:36 am | January 28, 2025
Most patients are interested in AI as a way to understand their care and their child's care, says Dr. Samuel Browd of UW and Seattle Children's, and the CMO at Proprio.
By Jeff Lagasse | 03:02 pm | January 27, 2025
The goal is to accelerate healthcare's shift to value-based care, Innovaccer says.
HIMSS25
By HIMSS TV | 09:51 am | January 27, 2025
At HIMSS25, Etay Maor, Cato Networks' chief security strategist, will address how attackers are targeting AI systems on the backend, where they're not detected.
By HIMSS TV | 10:15 am | January 22, 2025
Issues and plans include cybersecurity, optimizing claims processing to reduce denials, and modernizing patient digital access and experience, says Michael Mainiero, chief digital and information officer at Catholic Health Long Island.
By Jeff Lagasse | 10:55 am | January 21, 2025
Known as Care Alliance, the partnership centers largely on imaging services and access to diagnostic care.
By HIMSS TV | 11:00 am | January 17, 2025
The aim of Children's National Hospital is for artificial intelligence to enhance the ability to get to decisions faster for patient diagnoses and personalized treatment plans, as well as using AI to create efficiencies, says Alda Mizaku, chief data and AI officer.
By HIMSS TV | 11:00 am | January 16, 2025
The hospital was looking for someone to lead data, analytics and AI capabilities and to combine that with operations, says Alda Mizaku, chief data and AI officer.
By Susan Morse | 09:50 am | January 15, 2025
The health systems, Illumina, and Regeneron have invested $320M in what Truveta calls the largest and most diverse database for patient care.
By HIMSS TV | 10:16 am | January 14, 2025
The scribe needs specialty support to tackle the "edge" cases such as the complex care provided in the ER. It also needs to be coding-aware for the financial health of the hospital, says Dr. William Morris, Ambience Healthcare CMO.
By Jeff Lagasse | 03:08 pm | January 13, 2025
AI is especially prevalent across biopharma, with 30% of healthcare investment in 2024 going to companies leveraging AI.